)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
CureVac
CureVac (CVAC) investor relations material
CureVac Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary24 Nov, 2025
Executive summary
Clearance obtained from the German Federal Cartel Office for the planned BioNTech transaction, with the offer period running from October 21 to December 3, 2025.
Litigation with Pfizer/BioNTech over mRNA COVID-19 vaccines paused pending transaction completion.
Received EMA clearance for CVHNLC (sqNSCLC) clinical trial; CVGBM (glioblastoma) Phase 1 Part B remains on track.
Strong cash position of €416.1 million as of September 30, 2025, supporting runway into 2028.
Financial highlights
Revenues for Q3 2025 were €54.1 million and €56.3 million for the first nine months, down 89% year-over-year due to absence of a €480.4 million one-time GSK license revenue in 2024.
Operating profit for Q3 2025 was €310.2 million and €193.7 million for the first nine months, both lower than prior year due to reduced one-time effects.
Net profit for Q3 2025 was €273.2 million and €161.6 million for the first nine months, compared to €338.0 million and €194.9 million in 2024.
Basic and diluted EPS for Q3 2025 were €1.21; for the first nine months, €0.72 (basic) and €0.71 (diluted).
Outlook and guidance
Cash runway reaffirmed into 2028, supported by cost-saving measures and strategic restructuring.
Oncology pipeline progressing, with key milestones on track for CVGBM and CVHNLC programs.
Quantify EU APA audit financial risk
What is the expected outcome of paused litigation?
Explain cost reclassification impact on R&D
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from CureVac
- Record EUR 535.2M revenue and strong cash from GSK deal drive transformation and 2028 runway.CVAC
Q4 202417 Mar 2026 - CureVac advanced clinical programs, cut losses, and reaffirmed cash runway into 2028.CVACQ1 202517 Mar 2026
- Q3 GSK deal fueled record profit, cash, and pipeline growth, securing runway into 2028.CVACQ3 202415 Jan 2026
- BioNTech acquisition, patent settlement, and cost discipline drive improved outlook despite lower revenue.CVACQ2 202525 Aug 2025
- Strong financials, pipeline progress, and IP protection drive growth in mRNA innovation.CVACInvestor Presentation1 Jul 2025
- Streamlined operations and clinical advances drive growth, backed by strong cash and partnerships.CVACInvestor Presentation1 Jul 2025
- Strong cash position and pipeline progress drive growth in oncology and infectious diseases.CVACInvestor Presentation1 Jul 2025
- Focused R&D, strong financials, and pipeline progress drive growth in oncology and infectious diseases.CVACInvestor Presentation1 Jul 2025
- CureVac accelerates mRNA innovation with GSK partnership, restructuring, and oncology focus.CVACInvestor Presentation13 Jun 2025
Next CureVac earnings date
Q4 202524 Apr, 2026
CureVac
Next CureVac earnings date
Q4 202524 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage